Over the past 12 months, 7 insiders at TransMedics Group, Inc. filed 16 open-market SEC Form 4 transactions on TMDX: 4 purchases worth $3.0M and 12 sales worth $4.7M. Insiders have been net sellers over this period. The most recent filing was on Mar 4, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 26 | Stephanie LovellDirector | SELL | 1.2K | $149.62 | $178K |
| Mar 4, 26 | David WeillDirector | SELL | 3.6K | $146.82 | $524K |
| Mar 4, 26 | Gerardo HernandezChief Financial Officer | SELL | 5.9K | $147.21 | $870K |
| Mar 2, 26 | Gerardo HernandezChief Financial Officer | SELL | 375 | $139.12 | $52K |
| Mar 2, 26 | Anil P. RanganathSee remarks | SELL | 864 | $139.12 | $120K |
| Mar 2, 26 | Nicholas CorcoranSee remarks | SELL | 3.0K | $139.12 | $413K |
| Dec 4, 25 | Gerardo HernandezChief Financial Officer | SELL | 920 | $139.62 | $128K |
| Dec 3, 25 | David WeillDirector | SELL | 5.0K | $138.64 | $693K |
| Nov 25, 25 | Anil P. RanganathSee remarks | SELL | 3.0K | $145.22 | $436K |
| Nov 17, 25 | Waleed H HassaneinPresident & CEO | BUY | 8.8K | $114.00 | $1.0M |
| Oct 29, 25 | Edward M BasileDirector | SELL | 4.1K | $130.45 | $540K |
| Aug 7, 25 | Waleed H HassaneinPresident & CEO | BUY | 6.6K | $116.85 | $768K |
| Aug 6, 25 | Waleed H HassaneinPresident & CEO | BUY | 8.4K | $118.68 | $997K |
| Aug 4, 25 | Edward M BasileDirector | SELL | 4.1K | $125.51 | $520K |
| Jun 9, 25 | Anil P. RanganathSee remarks | SELL | 686 | $139.80 | $96K |
| May 27, 25 | Edward M BasileDirector | SELL | 5.0K | $126.45 | $632K |
| May 23, 25 | David WeillDirector | SELL | 732 | $123.88 | $91K |
| May 9, 25 | Edward M BasileDirector | SELL | 6.0K | $115.63 | $694K |
| Mar 3, 25 | Tamer I KhayalChief Commercial Officer | SELL | 2.4K | $76.43 | $184K |
| Jan 7, 25 | Tamer I KhayalChief Commercial Officer | SELL | 1.1K | $80.05 | $87K |
| Dec 2, 24 | Tamer I KhayalChief Commercial Officer | SELL | 1.1K | $86.40 | $94K |
| Nov 11, 24 | Tamer I KhayalChief Commercial Officer | SELL | 1.5K | $90.04 | $131K |
| Nov 5, 24 | Edward M BasileDirector | SELL | 5.3K | $84.30 | $441K |
| Nov 1, 24 | Tamer I KhayalChief Commercial Officer | SELL | 1.1K | $82.64 | $89K |
| Oct 15, 24 | Waleed H HassaneinPresident & CEO | SELL | 3.6K | $135.04 | $476K |
| Oct 1, 24 | Tamer I KhayalChief Commercial Officer | SELL | 900 | $154.86 | $132K |
| Sep 16, 24 | Waleed H HassaneinPresident & CEO | SELL | 3.2K | $156.48 | $484K |
| Sep 3, 24 | Tamer I KhayalChief Commercial Officer | SELL | 921 | $165.87 | $146K |
| Aug 27, 24 | Nicholas CorcoranSee Remarks | SELL | 10.0K | $176.02 | $1.8M |
| Aug 22, 24 | Waleed H HassaneinPresident & CEO | SELL | 25.0K | $175.00 | $4.4M |
| Aug 21, 24 | Waleed H HassaneinPresident & CEO | SELL | 20.0K | $171.03 | $3.4M |
| Aug 15, 24 | Waleed H HassaneinPresident & CEO | SELL | 4.5K | $171.86 | $770K |
| Aug 8, 24 | James R TobinDirector | SELL | 12.7K | $159.96 | $2.0M |
| Aug 7, 24 | Anil P. RanganathSee remarks | SELL | 4.3K | $152.20 | $653K |
| Aug 6, 24 | Edward M BasileDirector | SELL | 2.4K | $151.89 | $357K |
| Aug 1, 24 | Tamer I KhayalChief Commercial Officer | SELL | 510 | $166.00 | $79K |
| Jul 15, 24 | Waleed H HassaneinPresident & CEO | SELL | 2.5K | $147.28 | $367K |
| Jul 1, 24 | Tamer I KhayalChief Commercial Officer | SELL | 1.1K | $153.48 | $167K |
| Jun 14, 24 | Waleed H HassaneinPresident & CEO | SELL | 3.8K | $144.52 | $543K |
| Jun 5, 24 | Edward M BasileDirector | SELL | 1.2K | $138.08 | $165K |
| Jun 5, 24 | Anil P. RanganathSee remarks | SELL | 703 | $135.21 | $95K |
| Jun 3, 24 | Stephen GordonChief Financial Officer | SELL | 2.1K | $135.93 | $280K |
| Jun 3, 24 | Tamer I KhayalChief Commercial Officer | SELL | 921 | $135.97 | $122K |
| May 29, 24 | Stephen GordonChief Financial Officer | SELL | 9.3K | $141.80 | $1.3M |
| May 29, 24 | David WeillDirector | SELL | 1.2K | $141.65 | $169K |
| May 15, 24 | Waleed H HassaneinPresident & CEO | SELL | 5.5K | $136.26 | $743K |
| May 10, 24 | David WeillDirector | SELL | 2.5K | $129.82 | $325K |
| May 7, 24 | Edward M BasileDirector | SELL | 2.2K | $132.34 | $289K |
| May 6, 24 | Nicholas CorcoranSee Remarks | SELL | 3.2K | $129.91 | $419K |
| May 6, 24 | Stephen GordonChief Financial Officer | SELL | 15.0K | $128.00 | $1.9M |
Over the past 12 months, insiders at TransMedics Group, Inc. filed 4 open-market purchases worth $3.0M and 12 sales worth $4.7M on TMDX, which makes them net sellers over the period. The most recent Form 4 was filed on Mar 4, 26.
The largest recent open-market TMDX insider purchase in our data was $1.0M by Waleed H Hassanein, President & CEO, filed on Nov 17, 25.
7 different insiders at TransMedics Group, Inc. filed open-market SEC Form 4 transactions on TMDX over the last 12 months.
InsiderTape plots every TMDX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every TransMedics Group, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →